MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...

A new web-based tool utilizing AI can help pathologists detect prostate cancer faster, say Northeastern University researchers who developed the technology. Prostate cancer is the most common cancer ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...

For men at the highest risk of prostate cancer as determined by a polygenic risk score, the percentage found to have clinically significant disease was higher than the percentage that would have been ...

When U.S. Sen. Bob Casey of Pennsylvania courageously shared his prostate cancer diagnosis and surgery earlier this year, he credited the support of his family and his exceptional medical care for his ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

Several novel therapies for castration-resistant prostate cancer (CRPC) have been approved with randomized phase III studies with continuing observational research either planned or ongoing.

CLEVELAND, Ohio — When it comes to cancer, deciding on the best course of treatment can sometimes feel like a coin toss. However, doctors at University Hospitals have a new tool that helps them weigh ...

It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...

A new study has found that digital rectal examination alone or in combination with a blood test does not improve prostate cancer detection compared to the blood test alone. The findings suggest that ...

Prostate massages are a fairly unexplored thing for most men. Society isn’t exactly a judgment-free space, and the stigma associated with using prostate massagers can make it feel wrong to explore the ...

A large primary care analysis shows prostate cancer screening remains underused and inequitable, with notable gaps for ...